Black Hawk Acquisition (BKHAR) Stock: Why It's Up Today
Updated Oct 21, 2026, 4:00 PM ET · closing price
- Latest session (Wed Oct 21): $1.66, +$0.31 (+22.96%), volume 20.7x its 50-day average.
Sector peers moving today (SPACs & Blank Checks):ATII +36.82%DNMX -0.30%SVIV -0.20%VHCP -0.20%KOYN +0.20%
- Closed at $1.66, +22.96% vs the prior close of $1.35.
- Volume 1.03K shares, 20.7x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)
BKHAR jumps 23.0% to $1.66 on 20.7x normal volume. Closed at $1.66, +22.96% vs the prior close of $1.35. Day range $1.25–$1.66, opened at $1.40.
Why Did BKHAR Stock Move Today?
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 21, 2026 — BKHAR jumps 23.0% to $1.66 on 20.7x normal volume
- Closed at $1.66, +22.96% vs the prior close of $1.35. Day range $1.25–$1.66, opened at $1.40.
- Volume was 1.03K shares, 20.7x its 50-day average of 50 — unusually heavy trading.
- 52-week range $1.25–$1.66; today's close sits at 100% of that range, at a new 52-week high.
BKHAR bull case vs bear case (from the data)
- Latest fiscal-year net income: profit of $1.33M.
- High volatility: average daily move of 23.0% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
Latest BKHAR SEC 8-K & 10-Q Filings
Every SEC filing by or about BKHAR in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Net income: $1.07M (prior year $154.40K) (+596.1% vs Aug 31, 2025)
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 3.02 — Sold unregistered shares.
Sep 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 22, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 17, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 26, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
- Item 3.02 — Sold unregistered shares.
Aug 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Jul 15, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended May 31, 2026:
- Net income: $88.93K (prior year $520.54K) (-82.9% vs May 31, 2025)
Things to know before you trade BKHAR
- How much it moves: over the last 20 sessions the average daily move was 22.96% (largest 23.0%). That is a volatile stock.
- Liquidity: about 542 shares (≈$901) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.66 vs a range of $1.25–$1.66 (100% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 13, 2026; 10-Q Oct 6, 2026; 8-K Sep 24, 2026.
- Share count: 4.15M shares outstanding (Oct 6, 2026), +0.0% vs a year earlier.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
BKHAR market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 21, 2026 | 1.40 | 1.66 | 1.25 | 1.66 | 1.03K |
| Oct 16, 2026 | 1.20 | 1.35 | 1.35 | 1.35 | 50 |
About Black Hawk Acquisition
Black Hawk Acquisition (BKHAR) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in DANVILLE, CA. Fiscal year ends November 30. SEC CIK 2000775.
BKHAR board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BKHAR financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Nov 30, 2025 | — | $1.33M | — | $-650.32K |
| Nov 30, 2024 | — | $1.92M | — | $-553.66K |
Latest balance sheet: total assets $26.03M, total liabilities $4.75M, cash $0 (as of Aug 31, 2026).
BKHAR earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Space Exploration Technologies (SPCX)Meta Platforms (META)Tesla (TSLA)Apple (AAPL)Sandisk (SNDK)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BKHAR
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 21, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.